Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Biochem Pharmacol. 2021 Jul 16;192:114688. doi: 10.1016/j.bcp.2021.114688

Fig. 2.

Fig. 2.

Immunoblotting of fractions of DU-145 cells incubated with indicated drugs (10uM concentration for 16 Hrs). Fractions were separated using 4–20 % SDS-PAGE and immunoblotted using antibodies against STAT3, Histone H2B, GAPDH and Vimentin. Data are representative of three independently performed experiments.